Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clair Beard

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Urologic Oncology|July 24, 2004
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapyMona V Sanghani, Jane Ching, Delray Schultz, et al.
European Urology Focus|July 30, 2017
Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended ChemotherapyRowan E Miller, Sarah C Markt, Elizabeth O'Donnell, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilizationRosemonde Woel, Clair Beard, Ming-Hui Chen, et al.
Practical Radiation Oncology|June 28, 2016
Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012Jonathan J Paly, Chun Chieh Lin, Phillip J Gray, et al.
The Journal of Urology|May 19, 2007
Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancerMark Pomerantz, Judith Manola, Mary-Ellen Taplin, et al.
Urology|April 19, 2005
Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapyDaniel M Landis, Delray Schultz, Robert Cormack, et al.
Urology|December 11, 2003
Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostateAnthony V D'amico, Clare M Tempany, Delray Schultz, et al.
Urology|April 6, 2006
A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilizationAnthony V D'Amico, Judith Manola, Elizabeth McMahon, et al.
Cancer|August 31, 2010
Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancerClair Beard, William B Stason, Qian Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancerMette Sprauten, Thomas H Darrah, Derick R Peterson, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Urologic Oncology|July 24, 2004
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapyMona V Sanghani, Jane Ching, Delray Schultz, et al.
European Urology Focus|July 30, 2017
Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended ChemotherapyRowan E Miller, Sarah C Markt, Elizabeth O'Donnell, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilizationRosemonde Woel, Clair Beard, Ming-Hui Chen, et al.
Practical Radiation Oncology|June 28, 2016
Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012Jonathan J Paly, Chun Chieh Lin, Phillip J Gray, et al.
The Journal of Urology|May 19, 2007
Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancerMark Pomerantz, Judith Manola, Mary-Ellen Taplin, et al.
Urology|April 19, 2005
Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapyDaniel M Landis, Delray Schultz, Robert Cormack, et al.
Urology|December 11, 2003
Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostateAnthony V D'amico, Clare M Tempany, Delray Schultz, et al.
Urology|April 6, 2006
A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilizationAnthony V D'Amico, Judith Manola, Elizabeth McMahon, et al.
Cancer|August 31, 2010
Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancerClair Beard, William B Stason, Qian Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancerMette Sprauten, Thomas H Darrah, Derick R Peterson, et al.
Pageof 4